Research article Open access
Convalescent Plasma Therapy in Critically Ill COVID-19 Patients: An Open Label Trial
Objectives: The novel severe acute respiratory syndrome coronavirus 2 pandemic continues to spread globally without an effective treatment. In search of the cure, convalescent plasma (CP) containing protective antibodies from survivors of coronavirus disease 2019 (COVID-19) infection has shown potential benefit in a no …